206 related articles for article (PubMed ID: 24641386)
1. Diagnostic value of fecal calprotectin as a screening biomarker for gastrointestinal malignancies.
Khoshbaten M; Pishahang P; Nouri M; Lashkari A; Alizadeh M; Rostami-Nejad M
Asian Pac J Cancer Prev; 2014; 15(4):1667-70. PubMed ID: 24641386
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
[TBL] [Abstract][Full Text] [Related]
3. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
Li XG; Lu YM; Gu F; Yang XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
5. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
Summerton CB; Longlands MG; Wiener K; Shreeve DR
Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
[TBL] [Abstract][Full Text] [Related]
6. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
7. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
[TBL] [Abstract][Full Text] [Related]
8. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases.
Damms A; Bischoff SC
Int J Colorectal Dis; 2008 Oct; 23(10):985-92. PubMed ID: 18629518
[TBL] [Abstract][Full Text] [Related]
9. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics.
Kristinsson J; Armbruster CH; Ugstad M; Kriwanek S; Nygaard K; Tøn H; Fuglerud P
Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch-Schonlein purpura in children.
Teng X; Gao C; Sun M; Wu J
Clin Rheumatol; 2018 Jun; 37(6):1667-1673. PubMed ID: 29018973
[TBL] [Abstract][Full Text] [Related]
11. The use of fecal calprotectin as a biomarker in gastrointestinal disease.
Burri E; Beglinger C
Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):197-210. PubMed ID: 24345070
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin: assessment of a rapid test.
Vestergaard TA; Nielsen SL; Dahlerup JF; Hornung N
Scand J Clin Lab Invest; 2008; 68(4):343-7. PubMed ID: 17852834
[TBL] [Abstract][Full Text] [Related]
13. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
14. Faecal calprotectin as a marker for oesophago-gastric cancer.
Vincent Z; Hornby S; Ball S; Sanders G; Ayling RM
Ann Clin Biochem; 2015 Nov; 52(Pt 6):660-4. PubMed ID: 25732128
[TBL] [Abstract][Full Text] [Related]
15. Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients.
Boerlage TC; Westerink F; Poland DC; Huibregtse IL; Acherman YI; Gerdes VE
Obes Surg; 2016 Dec; 26(12):2974-2980. PubMed ID: 27216731
[TBL] [Abstract][Full Text] [Related]
16. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.
Manz M; Burri E; Rothen C; Tchanguizi N; Niederberger C; Rossi L; Beglinger C; Lehmann FS
BMC Gastroenterol; 2012 Jan; 12():5. PubMed ID: 22233279
[TBL] [Abstract][Full Text] [Related]
17. Faecal calprotectin levels in a high risk population for colorectal neoplasia.
Kronborg O; Ugstad M; Fuglerud P; Johne B; Hardcastle J; Scholefield JH; Vellacott K; Moshakis V; Reynolds JR
Gut; 2000 Jun; 46(6):795-800. PubMed ID: 10807890
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M
Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419
[TBL] [Abstract][Full Text] [Related]
20. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
Kristensen V; Klepp P; Cvancarova M; Røseth A; Skar V; Moum B
J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]